As of 2025-07-01, the Fair Value of Arecor Therapeutics PLC (AREC.L) is -135.55 GBP. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 43.50 GBP, the upside of Arecor Therapeutics PLC is -411.61%.
With the market price of 43.50 GBP and our fair value calculation, Arecor Therapeutics PLC (AREC.L) is not a good investment. Investing in AREC.L stocks now will result in a potential loss of 411.61%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -2.75 | -6.17 | -9.26 | -8.55 | -10.24 | -7.39 |
| YoY growth | -115.50% | -124.13% | -50.11% | 7.62% | -19.66% | -60.35% |
| Market Cap (mil) | 16.42 |
| P/E | |
| Forward P/E |
| EPS | -27.11 |
| Avg earnings growth rate | -60.35% |
| TTM earnings | -10.24 |